Compare J.B.Chemicals with ASTRAZENECA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs ASTRAZENECA PHARMA - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

ASTRAZENECA PHARMA 
   Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS ASTRAZENECA PHARMA J.B.CHEMICALS/
ASTRAZENECA PHARMA
 
P/E (TTM) x 39.0 117.1 33.3% View Chart
P/BV x 7.3 35.8 20.2% View Chart
Dividend Yield % 0.2 0.0 -  

Financials

 J.B.CHEMICALS   ASTRAZENECA PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
ASTRAZENECA PHARMA
Mar-18
J.B.CHEMICALS/
ASTRAZENECA PHARMA
5-Yr Chart
Click to enlarge
High Rs3631,278 28.4%   
Low Rs255883 28.9%   
Sales per share (Unadj.) Rs169.1228.4 74.1%  
Earnings per share (Unadj.) Rs16.610.4 160.2%  
Cash flow per share (Unadj.) Rs23.416.3 144.0%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs172.598.8 174.6%  
Shares outstanding (eoy) m83.5725.00 334.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.84.7 38.6%   
Avg P/E ratio x18.6104.2 17.9%  
P/CF ratio (eoy) x13.266.4 19.9%  
Price / Book Value ratio x1.810.9 16.4%  
Dividend payout %12.00-   
Avg Mkt Cap Rs m25,82727,008 95.6%   
No. of employees `0003.81.4 278.2%   
Total wages/salary Rs m2,5111,535 163.6%   
Avg. sales/employee Rs Th3,747.44,210.9 89.0%   
Avg. wages/employee Rs Th665.71,132.2 58.8%   
Avg. net profit/employee Rs Th367.8191.1 192.5%   
INCOME DATA
Net Sales Rs m14,1355,710 247.5%  
Other income Rs m366123 298.6%   
Total revenues Rs m14,5015,833 248.6%   
Gross profit Rs m2,178463 470.6%  
Depreciation Rs m570147 386.5%   
Interest Rs m350-   
Profit before tax Rs m1,940438 442.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m552179 308.7%   
Profit after tax Rs m1,387259 535.4%  
Gross profit margin %15.48.1 190.1%  
Effective tax rate %28.540.8 69.7%   
Net profit margin %9.84.5 216.3%  
BALANCE SHEET DATA
Current assets Rs m10,4703,209 326.2%   
Current liabilities Rs m2,7492,070 132.8%   
Net working cap to sales %54.620.0 273.7%  
Current ratio x3.81.6 245.6%  
Inventory Days Days5572 76.3%  
Debtors Days Days7835 222.4%  
Net fixed assets Rs m5,811790 735.3%   
Share capital Rs m16750 334.2%   
"Free" reserves Rs m14,2482,419 588.9%   
Net worth Rs m14,4162,469 583.8%   
Long term debt Rs m00-   
Total assets Rs m17,6494,605 383.2%  
Interest coverage x56.6NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.81.2 64.6%   
Return on assets %8.15.6 143.2%  
Return on equity %9.610.5 91.7%  
Return on capital %13.717.7 77.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,164300 2,057.7%   
Fx outflow Rs m1,3342,015 66.2%   
Net fx Rs m4,829-1,715 -281.5%   
CASH FLOW
From Operations Rs m1,23188 1,399.9%  
From Investments Rs m-208-94 222.3%  
From Financial Activity Rs m-595NA-  
Net Cashflow Rs m427-6 -7,493.0%  

Share Holding

Indian Promoters % 55.4 0.0 -  
Foreign collaborators % 0.3 75.0 0.4%  
Indian inst/Mut Fund % 3.4 0.3 1,130.0%  
FIIs % 3.9 15.7 24.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 9.1 406.6%  
Shareholders   30,437 12,856 236.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   CADILA HEALTHCARE  TTK HEALTHCARE  SHASUN PHARMA  DISHMAN PHARMA  FULFORD INDIA  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Zooms 661 Points, Nifty Ends Above 14,500; M&M and Bajaj Finserv Top Gainers(Closing)

Indian share markets witnessed most of the buying interest during closing hours today and ended on a strong note.

Related Views on News

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY21); Net Profit Down 21.2% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 211 m (down 21.2% YoY). Sales on the other hand came in at Rs 2 bn (down 10.5% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 13.4% (Quarterly Result Update)

Sep 22, 2020 | Updated on Sep 22, 2020

For the quarter ended June 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 186 m (down 13.4% YoY). Sales on the other hand came in at Rs 2 bn (down 5.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 2.5% (Quarterly Result Update)

May 20, 2020 | Updated on May 20, 2020

For the quarter ended March 2020, ASTRAZENECA PHARMA has posted a net profit of Rs 96 m (down 2.5% YoY). Sales on the other hand came in at Rs 2 bn (up 2.4% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

If the Market Falls, I Will Do This...(Fast Profits Daily)

Apr 1, 2021

What should you do if the market falls? In this video, I'll tell you what I will do.

The Indian Real Estate Party Has Just Begun(Profit Hunter)

Apr 1, 2021

A favourable demand supply scenario makes a strong case for real estate prices.

The Dilemma of Investing in Bharti Airtel(Views On News)

Apr 1, 2021

Rahul Shah on whether Bharti Airtel will emerge as the next big thing in the Indian stock market

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Apr 13, 2021 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS